Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by newdant

TSTIF

RE:After loosing $ 34 000 000...in 3 years and a half...

Yes the provision Rumble negotiated to have Stryker retain (one full year...

August 22, 2019

ABCAF

RE:RE:whats the risk?

Good insights. Thank you!

June 20, 2019

ABCAF

whats the risk?

Like this company but from Q1_2019.. The Corporation is exposed to...

June 19, 2019

TSTIF

RE:RE:RE:courage capital 13f

Yes you are right and I fully realize that. Seen this type of covenant waived...

June 19, 2019

TSTIF

RE:courage capital 13f

I do appreciate all of your posts StocksFTB but FYI the 5M term loan matures...

June 19, 2019

XEBEQ

RE:My Worry List

Some legit concerns that I don't have the answer to (political risks...

June 6, 2019

TSTIF

RE:RE:RE:RE:Selling price of sterilizers

FYI for all those guessing, @ 19.10 on the call GK states the asp for the 13...

March 29, 2019

V.FLY

I think a great deal of Flyht

as a company. It has great products and an excellent management team and BOD,...

March 25, 2019

NEPTF

RE:RE:RE:Aside from Valens here

I guess you're right. In the end you just have to make up your mind...

March 21, 2019

NEPTF

RE:RE:RE:Aside from Valens here

Wow. No sooner than I posted above I see this from SA again regarding NEPT...

March 21, 2019

NEPTF

RE:RE:Aside from Valens here

Actually Gold, they are not promoting, just trying to provide unbiased...

March 21, 2019

NEPTF

Aside from Valens here

is a March 13th blurb from SA on Neptunes other main competitor in the...

March 20, 2019

NEPTF

Seeking Alpha's

article this morning reinforces what I was able to discern through my own...

March 18, 2019

NEPTF

RE:RE:RE:RE:RE:RE:A reminder...

I originally read them on sedar but you should be able to find reference to...

March 14, 2019

NEPTF

RE:RE:RE:RE:A reminder...

The other thing that's rather ironic is that NEPT has cited they're...

March 13, 2019

NEPTF

RE:RE:A reminder...

Yes that's why I sold my position. Maybe NEPT will still do well but they...

March 12, 2019

TSTIF

RE:RE:RE:RE:RE:Volume dumps

One thing that may make the asp's more difficult to ascertain is if and...

March 11, 2019

TSTIF

RE:RE:RE:RE:RE:It doesn't matter what TOS reports for Q4

Vice - To get a BOD seat we would need to pool like minded retail investors...

March 6, 2019

TSTIF

RE:RE:RE:RE:RE:It doesn't matter what TOS reports for Q4

We'll have to wait and see what's reported over the next few quarters...

March 6, 2019

TSTIF

RE:RE:RE:It doesn't matter what TOS reports for Q4

I do share some of your concerns about additional future dilution. It's...

March 5, 2019

1 2 Next

Featured Company

Biosenta Inc.

Biosenta Inc. C.ZRO

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ... view more »